JW Pharmaceutical Corporation (KRX: 001060)

JW Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	38,775	15,909	33,898	33,366	10,451	41,864
Short-Term Investments	28,131	48,288	53,781	32,300	44,840	-
Trading Asset Securities	29,000	30,000	62,000	-	-	-
Cash & Short-Term Investments	95,906	94,196	149,678	65,666	55,291	41,864
Cash Growth	19.41%	-37.07%	127.94%	18.76%	32.07%	35.27%
Accounts Receivable	137,141	159,378	147,523	151,780	122,833	177,111
Other Receivables	2,938	5,644	5,962	5,499	5,296	5,662
Receivables	141,493	173,521	156,362	187,379	128,129	182,773
Inventory	116,436	106,091	111,668	102,528	101,198	90,442
Prepaid Expenses	1,577	1,848	1,774	5,152	3,434	2,383
Other Current Assets	5,619	2,434	5,975	5,727	11,276	17,595
Total Current Assets	361,029	378,091	425,457	366,452	299,329	335,057
Property, Plant & Equipment	153,718	155,724	123,048	118,392	185,572	150,430
Long-Term Investments	38,412	36,995	33,957	98,884	20,304	5,232
Goodwill	1,404	1,404	-	-	-	7,049
Other Intangible Assets	11,844	12,248	11,750	12,773	12,308	8,406
Long-Term Deferred Tax Assets	21,534	20,623	21,811	20,802	17,980	19,850
Long-Term Deferred Charges	25,177	16,704	4,516	8,700	5,358	5,940
Other Long-Term Assets	7,661	7,746	269.55	4,050	5,235	41,242
Total Assets	636,879	645,039	627,973	633,053	549,085	573,208
Accounts Payable	58,633	73,847	82,908	51,643	47,885	45,087
Accrued Expenses	21,532	14,495	12,472	10,343	4,992	4,930
Short-Term Debt	40,000	72,968	46,000	81,823	70,000	117,732
Current Portion of Long-Term Debt	41,666	40,166	160,440	39,977	36,466	37,221
Current Portion of Leases	4,401	4,270	1,253	1,274	849.5	928.32
Current Income Taxes Payable	12,853	11,114	10,153	24,877	326.34	-
Current Unearned Revenue	159.58	159.58	153.65	551.41	-	199.22
Other Current Liabilities	75,518	69,907	66,752	72,188	74,228	71,886
Total Current Liabilities	254,763	286,927	380,131	282,678	234,748	277,983
Long-Term Debt	27,500	30,000	-	120,744	73,585	30,183
Long-Term Leases	21,427	22,876	1,849	1,326	1,320	1,464
Long-Term Unearned Revenue	1,197	-	-	-	-	-
Long-Term Deferred Tax Liabilities	1,165	1,276	1,399	-	-	-
Other Long-Term Liabilities	11,960	28,198	11,520	17,364	4,994	4,714
Total Liabilities	333,112	379,598	402,214	444,514	341,618	343,116
Common Stock	62,253	61,100	59,418	57,202	55,616	54,092
Additional Paid-In Capital	68,321	69,475	71,063	63,334	64,522	66,046
Retained Earnings	151,810	113,029	89,130	58,595	65,084	86,789
Treasury Stock	-11,658	-11,325	-11,065	-10,783	-10,371	-10,146
Comprehensive Income & Other	33,040	33,162	31,808	32,847	32,640	33,301
Total Common Equity	303,767	265,440	240,354	201,195	207,491	230,082
Minority Interest	0	0	-14,595	-12,655	-24.04	10.14
Shareholders' Equity	303,767	265,440	225,759	188,540	207,467	230,092
Total Liabilities & Equity	636,879	645,039	627,973	633,053	549,085	573,208
Total Debt	134,994	170,280	209,542	245,145	182,220	187,527
Net Cash (Debt)	-39,089	-76,084	-59,864	-179,479	-126,929	-145,663
Net Cash Per Share	-681.90	-3260.29	-2577.51	-7733.47	-5466.27	-6275.64
Filing Date Shares Outstanding	23.32	23.33	22.34	22.35	22.36	22.37
Total Common Shares Outstanding	23.32	23.33	23.34	23.21	23.22	23.22
Working Capital	106,266	91,164	45,326	83,774	64,581	57,074
Book Value Per Share	13023.47	11375.92	10299.98	8669.19	8935.72	9906.76
Tangible Book Value	290,518	251,788	228,604	188,422	195,183	214,626
Tangible Book Value Per Share	12455.46	10790.83	9796.44	8118.81	8405.66	9241.27
Land	26,555	26,555	22,178	22,178	71,406	43,981
Buildings	66,516	112,052	110,929	110,161	136,003	116,215
Machinery	24,205	169,111	158,179	151,192	147,213	139,818
Construction In Progress	7,914	6,064	8,128	849.45	4,075	986.83

Source: S&P Capital IQ. Standard template. Financial Sources.